- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Novo Nordisk CEO agrees to testify on semaglutide pricing | ||
| Di | FDA clears Roche digital pathology platform for diagnosis | ||
| Di | AZ has another setback with Truqap after failed TNBC trial | ||
| Di | FDA says yes to MSD's 21-valent adult pneumococcal jab | ||
| Mo | Epilepsy fail hands late-stage pipeline blow to Takeda | ||
| Mo | Study finds low secondary cancer risk with CAR-Ts | ||
| Mo | New data at EHA backs Sanofi, Innate's NK cell engager | ||
| Mo | Telehealth firm fraud charges may worsen ADHD drug shortage | ||
| Fr | Radiopharma firm Telix abandons Nasdaq listing plans | ||
| Fr | DeepWell gamifies breathing therapy for mental health | ||
| Fr | FDA widens label for BMS' cancer drug Augtyro | ||
| Fr | AbbVie licenses FutureGen IBD drug in $1.7bn deal | ||
| Do | SCOTUS rejects challenge to abortion pill mifepristone | ||
| Do | Future of Pfizer's Duchenne gene therapy in doubt | ||
| Do | WuXi buoyed as BIOSECURE Act is left out of US spending bill | ||
| Do | Flagship, ProFound set off on obesity drug hunt for Pfizer | ||
| Do | Mahana's DTx for IBS gets permanent reimbursement in Germany | ||
| Do | NICE declines to look again at depression drug Spravato | ||
| 11.06. | GSK et al file appeal to Delaware Zantac order | ||
| 11.06. | EU orders bird flu vaccine supplies from CSL Seqirus | ||
| 11.06. | UK pharma industry delivers election 'wish list' | ||
| 11.06. | ALZpath licenses Alzheimer's diagnosis tech to Roche | ||
| 11.06. | FDA clears Ipsen's primary biliary cholangitis drug | ||
| 11.06. | Lilly's Alzheimer's drug set to join Leqembi after FDA vote | ||
| 10.06. | Moderna says COVID/flu shot clears phase 3 hurdle |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
